R1 RCM Inc. (NASDAQ:RCM) Given Average Recommendation of “Hold” by Analysts

Shares of R1 RCM Inc. (NASDAQ:RCM) have received an average rating of “Hold” from the seventeen ratings firms that are currently covering the company, MarketBeat reports. Twelve analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $15.73.

Separately, Cantor Fitzgerald restated a “neutral” rating and set a $14.30 price target on shares of R1 RCM in a research note on Friday, October 4th.

R1 RCM Stock Up 0.1 %

Shares of NASDAQ:RCM opened at $14.31 on Monday. The firm has a 50 day simple moving average of $14.27 and a 200 day simple moving average of $13.68. The company has a market cap of $6.04 billion, a PE ratio of -95.39 and a beta of 0.84. R1 RCM has a 52 week low of $8.87 and a 52 week high of $15.12. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.79 and a current ratio of 1.79.

R1 RCM (NASDAQ:RCM) last issued its earnings results on Tuesday, November 5th. The healthcare provider reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.04). R1 RCM had a negative net margin of 2.48% and a negative return on equity of 2.18%. The firm had revenue of $656.80 million during the quarter, compared to analysts’ expectations of $640.93 million. The business’s quarterly revenue was up 14.7% compared to the same quarter last year. As a group, research analysts expect that R1 RCM will post -0.18 earnings per share for the current year.

Institutional Trading of R1 RCM

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Tidal Investments LLC lifted its position in R1 RCM by 8.1% during the 3rd quarter. Tidal Investments LLC now owns 27,881 shares of the healthcare provider’s stock worth $395,000 after buying an additional 2,091 shares in the last quarter. Barclays PLC raised its stake in R1 RCM by 41.5% in the third quarter. Barclays PLC now owns 74,156 shares of the healthcare provider’s stock valued at $1,051,000 after purchasing an additional 21,754 shares in the last quarter. Public Employees Retirement System of Ohio boosted its position in shares of R1 RCM by 42.1% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 84,968 shares of the healthcare provider’s stock worth $1,204,000 after acquiring an additional 25,163 shares in the last quarter. Y Intercept Hong Kong Ltd bought a new stake in shares of R1 RCM during the 3rd quarter worth $446,000. Finally, EP Wealth Advisors LLC bought a new position in shares of R1 RCM in the third quarter worth about $168,000. 61.10% of the stock is owned by institutional investors.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.